Risk groups for hepatitis A virus infection

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2224-2233

  Franco, Elisabetta ^a   Giambi, Cristina ^a   Ialacci, Rita ^a   Coppola, Rosa C ^b   Zanetti, Alessandro R ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

HAV vaccine; Hepatitis A virus; Risk groups

Indexed keywords

HEPATITIS A VACCINE;

ARMY; ARTICLE; BLOOD TRANSFUSION; CAREGIVER; DAY CARE; DRUG DEPENDENCE; FOOD; HEALTH CARE PERSONNEL; HEMOPHILIA; HEPATITIS A; HEPATITIS A VIRUS; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; INSTITUTIONAL CARE; LIVER TRANSPLANTATION; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; PRISONER; RECIPIENT; RISK FACTOR; SEWAGE; TRAVEL; VACCINATION; VOLUNTEER;

EID: 0038403670     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00137-3     Document Type: Article

References (167)

1. Margolis S.H., Shapiro C.N. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy. Vaccine. 10(Suppl 1):1992;S85-S87.
2. Jilg W. Adult use of hepatitis A vaccine in developed countries. Vaccine. 11(Suppl 1):1993;S6-S9.
3. Gerson A.A. Present and future challenges of immunizations on the health of our patients. Pediatr. Infect. Dis. J. 14:1995;445-449.
4. Sagliocca L., Mele A., Ferrigno L.et al. Case-control study of risk factors for hepatitis A: Naples 1990-1991. Ital. J. Gastroenterol. 27:1995;181-184.
5. Anonymous. Workshop Consensus Conference, Roma, 1995. Ital J Gastroenterol 1996;28:181-4.
6. Bade T.F. Hepatitis A vaccine. Am. J. Gastroenterol. 91(2):1996;217-222.
7. Mele A., Stroffolini T., Palumbo F.et al. Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. J. Hepatol. 26:1997;743-747.
8. Hutin Y.J., Bell B.P., Marshall L.E.et al. Identifying target groups for a potential vaccination program during a hepatitis A community wide outbreak. Am. J. Public Health. 89(6):1999;918-921.
9. Kemmer N.M., Miskovsky M.D. Hepatitis A. Infect. Dis. Clin. North Am. 14(3):2000;605-615.
10. Slusarczyk J. Vaccination against hepatitis viruses in Poland. Vaccine. 19:2001;2384-2388.
11. Hall A.J. Hepatitis in travellers: epidemiology and prevention. Br. Med. Bull. 49(2):1993;382-393.
12. Steffen R., Kane A., Shapiro C.N.et al. Epidemiology and prevention of hepatitis A in travellers. J. Am. Med. Assoc. 272(11):1994;885-889.
13. Steffen R. Hepatitis A in travellers: the European experience. JID. 171(Suppl 1):1995;S24-S28.
14. Clayson E.T., Innis B.L., Myint K.S.A.et al. Short report: relative risk of hepatitis A and E among foreigners in Nepal. Am. J. Trop. Med. Hygiene. 52(6):1995;506-507.
15. Wolfe M.S. Hepatitis A and the American traveler. J. Infect. Dis. 171(Suppl 1):1995;S29-S31.
16. Smalligan R.D., Lange W.R., Frame J.D.et al. The risk of viral hepatitis A, B, C and E among North America missionaries. Am. J. Trop. Med. Hygiene. 53(3):1995;233-236.
17. Mele A., Sagliocca L., Palombo F.et al. Travel-associated hepatitis: effect of place of residente and country visited. J. Public Health Med. 13(4):1991;256-259.
18. Moore P., Oakeshott P., Logan J.et al. Prophylaxis against hepatitis A for travel. Br. Med. J. 300:1990;723-724.
19. Masterton R.G., Strike P.W., Tettmar R.E. Hepatitis A immunity and travel history. J. Infect. 23:1991;321-326.
20. Studer S., Joller-Jemela H.I., Steffen R.et al. Prevalence of hepatitis A antibodies in Swiss travellers. Eur. J. Epidemiol. 9(1):1993;50-54.
21. Hanse H.L., Andersen P.L., Brandt L.et al. Antibodies against hepatitis viruses in merchant seamen. Scand. J. Infect. Dis. 27:1995;191-194.
22. Anonymous. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travellers. MMWR 1995;44(29):559-60.
23. Anonymous. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. Pediatrics 1996;98(6):1207-15.
24. Larouze B., Bouchaud O., Dazza M.C.et al. Prevention des hepatites virales chez les voyageurs et ls expatries en milieu tropical et subtropical. Rev. Epidem. Sante Publ. 46:1998;56-62.
25. Dick L. Travel medicine: helping patients prepare for trips abroad. Am Family Physician 1998;58(2)383-98, 401-2.
26. Thomas R. Preparing patients to travel abroad safely. Can. Family Physician. 46:2000;646-656.
27. Mitka M. Travellers need hepatitis and other immunizations. J. Am. Med. Assoc. 283(17):2000;2226-2227.
28. Webster G., Barnes E., Dusheiko G. Protecting travellers from hepatitis A. Br. Med. J. 322:2001;1194-1195.
29. Prazuck T., Semaille C., Defayolle M.et al. Resp-informations. Rev. Epidem. Sante Publ. 46:1998;64-72.
30. Hawkins R.E., Malone J.D., Cloninger Laet al. Risk of viral hepatitis among military personnel assigned to US Navy Ships. JID. 165:1992;716-719.
31. Hoke C.H., Binn L.N., Egan J.E.et al. Hepatitis A in the US Army: epidemiology and vaccine development. Vaccine. 10(Suppl 1):1992;S75-S79.
32. Aarhaug P. Field evaluation of hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon. Vaccine. 10(Suppl 1):1992;S156-S158.
33. Green S.M., Tsur S., Slepon R. Socioedemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adult in Israel: implications for the new hepatitis A vaccines. Int. J. Epidemiol. 21(1):1992;136-141.
34. Joussemet M., Bourin P., Lebot O.et al. Evolution of hepatitis A antibodies prevalence in young French military recruits. Eur. J. Epidemiol. 8(2):1992;289-291.
35. Stroffolini T., D'Amerio R., Matricardi P.M.et al. The changing epidemiology of hepatitis A in Italy. Ital. J. Gastroenterol. 25:1993;372-374.
36. Lagarde E., Joussement M., Lataillade J.J., Fabre G. Risk factors for hepatitis A infection in France: drinking tap water may be of importance. Eur. J. Epidemiol. 11:1995;145-148.
37. Beran J., Douda P., Prymula R.et al. Hepatitis A vaccination by Havrix in the Czech U.N. troops according to data of seroprevalence in 1991-1995. Centre Eur. J. Public Health. 2:1996;87-90.
38. Dulat C., Defrance J.P., Ille H. Statut immunologique des militaires d'origine antillaise vis-avis du virus de l'hepatite A: incidence sur la prophylaxie. Med. Trop. 56:1996;255-258.
39. Gdalevic M., Grotto I., Mandel Y.et al. Hepatitis antibody prevalence among young adults in Israel: the decline continues. Epidemiol. Infect. 121:1998;477-479.
40. Joussement M., Depaquit J., Nicand E.et al. Effondrement de la seroprevalence de l'hepatite virale A chez les jeunes francais. Gastroenterol. Clin. Biol. 23:1999;447-452.
41. Hesla P.E. Hepatitis A in Norvegian troops. Vaccine. 10(Suppl 1):1992;S80-S81.
42. Coursaget P., Buisson Y., Enogat N.et al. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. J. Hepatol. 28:1998;745-750.
43. Matricardi P.M., D'Amelio R., Biselli R.et al. Incidence of hepatitis A virus infection among an Italian military population. Infection. 22(1):1994;51-55.
44. D'Amelio R., Molica C., Biselli R., Stroffolini T. Surveillance of infectious diseases in the Italian militars as pre-requisite for tailored vaccination programme. Vaccine. 19:2001;2006-2011.
45. Samson T., Buisson Y. Hepatites virales chez les militaires francais de la Forpronu. Rev. Epidem. Sante Publ. 44:1996;465-469.
46. Rosemblum L.S., Villarino M.E., Nainan O.V.et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J. Infect. Dis. 164:1991;476-482.
47. Lee K.K., Vargo L.R., Le C.T.et al. Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 11(2):1992;122-123.
48. Doebbeling B.N., Li N., Wenzel R.P. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am. J. Public Health. 83:1993;1679-1684.
49. Germanaud J., Kausse X., Barthets J.P. Prevalence of antibodies to hepatitis A virus in health care workers. Eur. J. Clin. Microbiol. Infect. Dis. 12:1993;572-573.
50. Burkholder B.T., Coronado V.G., Brown J.et al. Nosocomial transmission of hepatitis A in a pediatric hospital traced to an anti-hepatitis A virus-negative patient with immunodeficiency. Pediatr. Infect. Dis. J. 14:1995;261-266.
51. Sepkowitz K.A. Occupationally acquired infections in health care workers. Ann. Intern. Med. 125:1996;917-928.
52. Jensenius M., Ringertz S.H., Berild D.et al. Prolonged nosocomial outbreak of hepatitis A arising from an alcoholic with pneumonia. Scand. J. Infect. Dis. 30:1998;119-123.
53. Poole C.J.M., Shakespeare A.T. Immunity to hepatitis A in paediatric and nursery nurses. Occup. Med. 46(5):1996;361-363.
54. Trevisan A., Stocco E., Fanelli G.et al. Seroprevalence of hepatitis A markers in subjects exposed to biological risk. Int. Arch. Occup. Environ. Health. 72:1999;125-127.
55. Borg M.A., Portelli A. Hospital laundry workers - an at-risk group for hepatitis A? Occup. Med. 49(7):1999;448-450.
56. Hofmann F., Wehrle G., Berthold H.et al. Hepatitis A as an occupational hazard. Vaccine. 10(Suppl 1):1992;S82-S84.
57. Djeriri K., Fontana L., Laurichesse H.et al. Seroprevalence des marqueurs des hepatites virales A, B et C, parmi le personnel hospitalier du centre hospitalo-universitaire de Clermont-Ferrand. La Presse Medicale. 25(4):1996;145-150.
58. Nguyen-Khac E., Delcenserie R., Capron D.et al. Seroprevalence de l'hepatite virale A au Chu s'Amiens. Gastroenterol. Clin. Biol. 20:1996;36-41.
59. Vranckx R., Jacques P., Moens G. Prevalence of hepatitis A antibodies in a large sample of Belgian health care workers. Infection. 27(4-5):1999;256-258.
60. Domart M., Mlika-Cabanne N., Henzel D.et al. Hepatitis A among health care workers in Paris hospitals. J. Med. Virol. 58:1999;321-324.
61. Ashkenazi M., Chodik G., Littner M.et al. The presence of hepatitis A antibodies in dental workers. A seroepidemiologic study. JADA. 132:2001;492-498.
62. Beekmann S.E., Doebbeling B.N. Frontiers of occupational health. Infect. Dis. Clin. North Am. 11(2):1997;313-329.
63. Vonstille W.T., Stille W.T. III, Shaker R.C. Hepatitis A epidemic from utility sewage in Ocoee, Florida. Arch. Environ. Health. 48(2):1993;120-124.
64. De Serres G., Laliberté D. Hepatitis A among workers from a waste water treatment plant during a small community outbreak. Occup. Environ. Med. 54:1997;60-62.
65. Warlen A.A., Hoff G.L. Hepatitis A in waste water treatment plant workers: is vaccination necessary? JOEM. 40(6):1998;515-517.
66. Anonymous. Should sewage workers and carers for people with learning disabilities be vaccinated for hepatitis A? Br Med J 1993;306:1102.
67. Heng B.H., Goh K.T., Doraisingham S.et al. Prevalence of hepatitis A virus infection among sewage workers in Singapore. Epidemiol. Infect. 113:1994;121-128.
68. De Serres G., Lavesque B., Higgins R.et al. Need for vaccination of sewer workers against lepospirosis and hepatitis A. Occup. Environ. Med. 52:1995;505-507.
69. Cadilhac P., Roudot-Thoraval F. Seroprevalence of hepatitis A virus infection among sewage workers in the Parisian area, France. Eur. J. Epidemiol. 12:1996;237-240.
70. Brugha R., Heptonstall J., Farrington P.et al. Risk of hepatitis A infection in sewage workers. Occup. Environ. Med. 55:1998;567-569.
71. Levin M., Froom P., Trajber I.et al. Risk of hepatitis A virus infection among sewage workers in Israel. Arch. Environ. Health. 55(1):2000;7-10.
72. Trout D., Mueller C., Venczel L.et al. Evaluation of occupational transmission of hepatitis A virus among wastewater workers. JOEM. 42(1):2000;83-87.
73. Weldon M., VanEgdom M.J., Handricks K.et al. Prevalence of antibody to hepatitis A virus in drinking water workers and wastewater workers in Texas from 1996 to 1997. JOEM. 42(8):2000;821-826.
74. Bonanni P., Comodo N., Pasqui R.et al. Prevalence of hepatitis A virus infection in sewage plant workers of central Italy: is indication for vaccination justified? Vaccine. 19:2001;844-849.
75. Lerman Y., ChodiK G., Aloni H.et al. Occupations at increased risk of hepatitis A: a 2-year nationwide historical prospective study. Am. J. Epidemiol. 150(3):1999;312-320.
76. Bianco E., Calabrese R.M., Ferrara P.A., Franco E. Infezione da virus dell'epatite A ed alimenti: correlazioni epidemiologiche e misure di prevenzione. NPT. 2:1998;21-24.
77. Koster D., Hofmann F., Berthold H.et al. Hepatitis A immunity in food-handling occupations. Eur. J. Clin. Microbiol. Infect. Dis. 9:1990;304-305.
78. Mishu B., Hadler S.C., Boats V.A.et al. Foodborne hepatitis A: evidence that microwaving reduces risk? J. Infect. Dis. 162:1990;655-658.
79. Weltman A.C., Bennett N.M., Hackman D.A.et al. An outbreak of hepatitis A associated with a bakery, New York 1994: the 1968 "West branch, Michigan" outbreak repeated. Epidemiol. Infect. 117:1996;333-341.
80. Massoudi M.S., Bell B.P., Paredes V.et al. An outbreak of hepatitis A associated with an infected foodhandler. Public Health Rep. 114:1999;157-164.
81. Staes C.J., Schlenker T.L., Risk I.et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. 106(4):2000;e54.
82. Romano F., Bassani T., Capuani M.A.et al. Prevalenza di anticorpi anti-HAV in alimentaristi. Ann. Ig. 8:1996;419-423.
83. Hurwitz ES, Deseda CC, Shapiro CN, et al. Hepatitis infections in day care setting. Pediatrics 1994;6 pt 2:1023-4.
84. Castelli F., Mattelli A., Signorini L.et al. Pediatric migration and hepatitis A risk in host population. J. Travel Med. 6(3):1999;204-206.
85. Desenclos J.C.A., MacLafferty L. Community wide outbreak of hepatitis A linked to children in day care centres with increased transmission in young adult men in Florida 1988-9. J. Epidemiol. Commun. Health. 47:1993;269-273.
86. Severo C.A., Abensur P., Buisson Y.et al. An outbreak of hepatitis A in a French day care center and efforts to combat it. Eur. J. Epidemiol. 13:1997;139-144.
87. Sadetzki S., Rostmi N., Modan B. Hepatitis A outbreak originating in a day care center: a community case report. Eur. J. Epidemiol. 15:1999;549-551.
88. Venczel LV, Desai MM, Vertz PD, et al. The role of child care in a community-wide outbreak of hepatitis A. Pediatrics 2001;108(5).
89. Jacques P., Moens G., Van Damme P., Goubau P.et al. Increased risk for hepatitis A among female day nursery workers in Belgium. Occup. Med. 44:1994;259-261.
90. Jackson L.A., Stuart W.L.K., Solomon S.L.et al. Risk of infection with hepatitis. Pediatr. Infect. Dis. J. 15:1996;584-589.
91. Laurichesse H., Henquelle C., Gourdon F.et al. Hepatitis A and B in person with learning disabilities living in institutions: the need for vaccination. Infection. 26(2):1998;133-134.
92. Bell J.C., Crewe E.B., Capon A.G. Seroprevalence of hepatitis A antibodies among residents of a centre for people with developmental disabilities. Aust. New Zealand Med. 24:1994;365-367.
93. Gil A., Gonzalez A., Dal-Ré R.et al. Prevalence of hepatitis A in an institution for the mentally retarded in an intermediate endemicity area: influence of age length of institutionalization. J. Infect. 38:1999;120-123.
94. Sepetjan N., Garrigue J.L., Chossegros P.et al. Prevalence des infections a VHA et VHB dans les collectivites d'enfants de la région Lyonnaise. Med. Hygiene. 52:1994;344-353.
95. Lagarder B. Vaccination contre l'hepatite A. Arch. Pediatr. 5:1998;321-325.
96. Bianco C. Hepatitis testing. Immunol. Invest. 24(1-2):1995;155-161.
97. Tegtmeier G.E. Infectious diseases transmitted by transfusion: a miscellanea. Vox Sang. 67(Suppl 3):1994;179-181.
98. Mangiagli A. Prevalenza degli anticorpi antiepatite A nei pazienti talassemici politrsfusi. Pediatr. Med. Chir. 19:1997;437-438.
99. Mannucci P.M. Outbreak of hepatitis A among Italian patients with Haemophilia. Lancet. 339:1992;819.
100. Gerritzen A., Schneweis K.E., Brackman H.H.et al. Acute hepatitis A in haemophiliacs. Lancet. 340:1992;1231-1232.
101. Temperley I.J., Cotter K.P., Walsh T.J., Power J., Hillary I.B. Clotting factors and hepatitis A. Lancet. 340:1992;1466.
102. Peerlinck K., Vermylen J. Acute hepatitis A in patients with haemophilia A. Lancet. 341:1993;179.
103. Kedda M.A., Kew M.C., Cohn R.J.et al. An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source. Hepatology. 22(5):1995;1363-1367.
104. Anonymous. Hepatitis A among person with haemophilia who received clotting factor concentrate-United States, September-December 1995. MMWR 1996;45(2):29-32.
105. Robertson B.H., Alter M.J., Bell B.P.et al. Hepatitis A virus sequences detected in clotting factor concentrates associated with diseases transmission. Biologicals. 26:1998;95-99.
106. Soucie J.M., Robertson B.H., Bell P.B.et al. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Transfusion. 38:1998;573-579.
107. Chudy M., Budek I., Keller-Stanislawski B.et al. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool. J. Med. Virol. 57:1999;91-99.
108. Richardson L.C., Evatt B.L. Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products. Transf. Med. Rev. 44(1):2000;64-73.
109. Lawlor E., Graham S., Davidson F.et al. Hepatitis A transmission by factor IX concentrates. Vox Sang. 71:1996;126-128.
110. Guilaume T.A. Outbreaks of hepatitis A and emergence of new AIDS-associated agents: the need to add terminal 100°C dry-heat sterilization to factor VIII and factor IX concentrates. Vox Sang. 65:1993;158.
111. Scaraggi F.A., Perricci A., Petronelli M. Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacs. Lancet. 339:1992;1486-1487.
112. Robinson S.M., Schwin H., Smith A. Clotting factors and hepatitis A. Lancet. 340:1992;1465.
113. Kreutz W., Klarman D., Auerswald G.et al. Absence of hepatitis A after treatment with pasteurized factor VIII concentrates in children with haemophilia A and von Villebrand diseases. Lancet. 341:1993;446.
114. Nowicki M.J., Mosley J.W., Koerper M.A.et al. Passive antibody to hepatitis A virus in US haemophiliacs. Lancet. 341:1993;562.
115. Evensen S.A., Rollag H. Solvent/detergent-treated clotting factors and hepatitis A virus seroconversion. Lancet. 341:1993;971-972.
116. Kumar A., Kulkarmi R., Murray D.L.et al. Serologic markers of viral hepatitis A, B, C and D in patients with haemophilia. J. Med. Virol. 41:1993;205-209.
117. Berntorp E. Viral safety issues: plasma-derived factor VIII. Ann. Hematol. 68:1994;S35-S36.
118. Mannucci P.M., Gdovin S., Gringeri A.et al. Transmission of hepatitis A to patients with haemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann. Intern. Med. 120:1994;1-7.
119. Rothschild C., Pol S., Matlinger B.et al. Vaccination against hepatitis A virus in French haemophilic children. Vox Sang. 69:1995;80-81.
120. Johnson Z., Thornton L., Tobin A.et al. An outbreak of hepatitis A among Irish haemophiliacs. Int. J. Epidemiol. 24(4):1995;821-828.
121. Koblin B.A., Hilgartner M., Lipton R.et al. A study of hepatitis A virus infection among haemophilia patients in New York City. Transfusion. 35(4):1995;362-363.
122. Mauser-Bunschoten E.P., Zaaijer H.L., VanDreimmelen A.A.J.et al. Risk of hepatitis A in Dutch haemophilia patients. Thromb. Haemost. 74(2):1995;616-618.
123. Naef M.R., Bucher H.C., Erb P.et al. Reduced infection with HIV and hepatitis A during a Swiss intravenous opiate maintenance program. JAIDS. 21(4):1999;349-350.
124. Shapiro N., Coleman P.J., McQuillan G.M.et al. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine. 10(Suppl 1):1992;S59-S62.
125. Laskus T., Radkwoski M., Lupa E.et al. Prevalence of hepatotropic viruses among drug addicts in Warsaw. Poland J. Hepatol. 15:1992;114-117.
126. Struve J., Kall K., Stendahl P.et al. Prevalence of hepatitis B virus markers among intravenous drug abusers in Stockholm: impact of heterosexual transmission. Scand. J. Infect. Dis. 25:1993;8-13.
127. Patti A.M., Santi A.L., Giustini C.et al. Viral hepatitis and drugs: a continuing problem. Int. J. Epidemiol. 22(1):1993;135-139.
128. Lucht F., Berthelot P., Job P.et al. Seroprevalence de l'hepatite virale A en France metropolitaine chez les homosexueles et les toxicomanes intraveineux. La Presse Medicale. 25(25):1996;1141-1143.
129. Villano S.A., Nelson K.E., Vlahov D.et al. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin. Infect. Dis. 25:1997;726-728.
130. Croft N., Cooper G., Stewart T.et al. Exposure to hepatitis A virus among blood donors. J. Viral Hepatitis. 4:1997;333-338.
131. Shaw D.D., Whiteman D.C., Merritt A.D.et al. Hepatitis A outbreaks among illicit drug users and their contacts in Queensland, 1997. MJA. 170:1999;584-587.
132. Iwarson S. New target groups for vaccination against hepatitis A: homosexual men. Scand. J. Infect. Dis. 30(3):1998;316-318.
133. Grinde B., Stene-Johansen K., Sharma B.et al. Characterization of an epidemic of hepatitis A virus involving intravenous drug abusers. Infection by needle sharing? J. Med. Virol. 53:1997;69-75.
134. Kani J., Gilson R.J.C., Nandwani R.et al. Hepatitis A virus infection among homosexual men. Br. Med. J. 302:1991;1399.
135. Schomer K, Douglas JM, Cohn DL. Hepatitis A among homosexual men - United States, Canada and Australia. MMRW 1992;41(19):155, 161-4.
136. Atkins M., Zambon M., Watkins P. Should susceptible homosexual men be offered immunization? Br. Med. J. 307:1993;562.
137. Valiquette L., Dion R., Bedard L. Releve des maladies transissibles au Canada. Can. Commun. Dis. Rep. 22(16):1996;133-135.
138. Walsh B., Sundkvist T., Maguire H.et al. Rise in hepatitis A among gay men in the Thames regions 1995 and 1996. Genitourin. Med. 72(6):1996;449-450.
139. Sundkvist T., Aitken C., Duckworth G.et al. Outbreak of acute hepatitis A among homosexual men in east London. Scand. J. Infect. Dis. 29:1997;211-212.
140. Stokes M.L., Ferson M.J., Young L.C. Outbreak of hepatitis A among homosexual men in Sydney. Am. J. Public Health. 87(12):1997;2039-2041.
141. Anonymous. Hepatitis A vaccination of men who have sex with men-Atlanta, Georgia, 1996-1997. MMWR 1998;47(34):708-11.
142. Ferson M.J., Young L.C., Stokes L.M. Changing epidemiology of hepatitis A in the 1990s in Sydney. Aust. Epidemiol. Infect. 121:1998;631-636.
143. Newell A., Asboe D., Azadian B. Outbreak of hepatitis A in homosexual men in Riverside. Sex Transm. Infect. 74(4):1998;304-305.
144. Allard R., Beuchemin J., Bedard L.et al. Hepatitis A vaccination during an outbreak among gay men in Montreal, Canada, 1995-1997. J. Epidemiol. Commun. Health. 55:2001;251-256.
145. Leentvaar-Kuijpers A., Kool J.L., Veugelers P.L.et al. An outbreak of hepatitis A among homosexual men in Amsterdam, 1991-1993. Int. J. Epidemiol. 24(1):1995;218-222.
146. Henning K.J., Bell E., Braun J.et al. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am. J. Med. 29:1995;132-136.
147. Reintjes R., Bosman A., de Zwart O., Stevens M.et al. Outbreak of hepatitis A in Rotterdam associated with visit to 'darkrooms' in gay bars. Commun. Dis. Public Health. 2(1):1999;43-46.
148. Edwards S., Carne C. Oral sex and the transmission of viral STIs. Sex Transm. Infect. 74:1998;6-10.
149. Nandawani R., Caswell S., Boag F.et al. Hepatitis A seroprevalence in homosexual and heterosexual men. Genitourin. Med. 70:1994;325-328.
150. Ballesteros J., Dal-Ré R., Gonzales A.et al. Are homosexuals males a risk group for hepatitis A infection in intermediate endemicity areas? Epidemiol. Infect. 117:1996;145-148.
151. Katz M.H., Hsu L., Wong E.et al. Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. JID. 175:1997;1225-1229.
152. Corona R., Stroffolini T., Giglio A.et al. Lack of evidence for increase risk of hepatitis A infection in homosexual men. Epidemiol. Infect. 123:1999;89-93.
153. Brook M.G. Sexual transmission and prevention of the hepatitis viruses A-E and G. Sex Transm. Infect. 74:1998;395-398.
154. Levy I.G., Gemill I., Ellis E.C. Hepatitis A among men in a Canadian correctional facility. Can. Commun. Dis. Rep. 19(3):1993;17-21.
155. Whiteman D., McCall B., Falconer A. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control. J. Viral. Hepatitis. 5:1998;277-283.
156. Nguyen C., Lebel F. Acute retroviral syndrome complicated by cytomegalo virus and hepatitis A coinfection. JID. 164:1991;219-220.
157. Fonquernie L., Meynard L., Charrois A.et al. Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus. CID. 32:2001;297-299.
158. Gane E., Saliie R., Saleh M.et al. Clinical recurrence of hepatitis A following liver transplantation for acute liver failure. J. Med. Virol. 45(1):1995;35-39.
159. Tibbs C., Williams R. Vireal causes and management of acute liver failure. J. Hepatol. 22(Suppl 1):1995;68-73.
160. Gunther M., Stark K., Neuhaus R.et al. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 71(3):2001;477-490.
161. Arslan M., Wiesner R.H., Poterucha J.J.et al. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation. 72(2):2001;272-276.
162. Aparicio T., Driss F., Thepot V.et al. Sero-epidemiologie de l'hepatite A: les alcooliques sont un groupe a risque. Gastroenterol. Clin. Biol. 19:1995;751-755.
163. Taylor M.B., Becker P.J., Van Rensburg E.J.et al. A serosurvey of water-borne pathogens among canoeists in South Africa. Epidemiol. Infect. 115:1995;299-307.
164. Michielsen P.P., Van Damme P. Viral hepatitis and pregnancy. Acta Gastroenterol. Belg. LXIII:1999;21-29.
165. Zhu J., Quyyumi A.A., Norman J.E.et al. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. JID. 182:2000;1583-1587.
166. Zhu J., Nieto J., Horne B.D.et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 103:2001;45-51.
167. Smieja M., Cronin L., Levine M.et al. Previous exposure to Clamydia Pneumoniae, Helicobacter Pylori and other infections in Canadian patients with ischemic hearth diseases. Can. J. Cardiol. 17(3):2001;270-276.